Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the world’s leading clinicians to improve procedural and patient outcomes.
InnovaHealth Partners invested in Route 92 Medical in June and December 2021. Ariella Golomb, M.D., is a member of the Route 92 Medical Board of Directors and Mortimer Berkowitz III is an observer.
